Letter : vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD. Authors' reply

Details

Database :

OAIster

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1261883458

Document Type :

Electronic Resource

Full Text :

https://doi.org/10.1111.apt.16352